Meet our team

"To gain the most for patients from a chiral switch, you have to both forget and remember.  Forgetting the racemic parent drug means developing the superior enantiomer like a completely new drug, optimizing its benefits and maximizing differentiation, while at the same time remembering the lessons of the past work to accelerate the process and avoid pitfalls."

–  Bill McVicar, Neuromity, CEO